Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm

Detalles Bibliográficos
Autores principales: Pedersen, Kasper Mønsted, Çolak, Yunus, Hasselbalch, Hans Carl, Bojesen, Stig Egil, Nordestgaard, Børge Grønne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205745/
https://www.ncbi.nlm.nih.gov/pubmed/32395710
http://dx.doi.org/10.1016/j.eclinm.2020.100337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205745/
https://www.ncbi.nlm.nih.gov/pubmed/32395710
http://dx.doi.org/10.1016/j.eclinm.2020.100337

Ejemplares similares